nach oben

memo - Magazine of European Medical Oncology

Erschienen in:

01.12.2021 | ASCO 2021 | editorial

Best of ASCO 2021

verfasst von: Univ.-Prof. Dr. Ewald Wöll

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 4/2021

Einloggen, um Zugang zu erhalten

Excerpt

In the current issue of the Magazine of European Medical Oncology (MEMO), we provide a series of articles summarizing the most relevant presentations delivered at ASCO 2021 on central nervous system tumors, upper gastrointestinal (GI) cancers, triple-negative breast cancer (TNBC), nasopharyngeal carcinoma, early stage non-small cell lung cancer, advanced ovarian cancer, bladder cancer, and metastastic colorectal cancer. …

Nächster Artikel Practical issues in hematology

Mair MJ, Berghoff AS. ASCO 2021: Highlights in central nervous system tumors. memo. 2021;14(4). https://doi.org/10.1007/s12254-021-00752-y.CrossRef

Ilhan-Mutlu A. ASCO 2021–Gastroesophageal tumor highlights. memo. 2021;14(4). https://doi.org/10.1007/s12254-021-00751-z. CrossRef

Singer C. Best of ASCO 2021: new data from triple-negative breast cancer. memo. 2021;14(4). https://doi.org/10.1007/s12254-021-00750-0.CrossRef

Fuereder T. ASCO 2021 highlights head and neck cancer: nasopharyngeal carcinoma. memo. 2021;14(4). https://doi.org/10.1007/s12254-021-00758-6.CrossRef

Absenger G, Pircher A. ASCO 2021—selection of personal highlights in early stage non-small cell lung cancer. memo. 2021;14(4). https://doi.org/10.1007/s12254-021-00770-w.CrossRef

Schöche J, Strasser-Weippl K. Ovarian cancer—ASCO annual meeting update 2021. memo. 2021;14(4). https://doi.org/10.1007/s12254-021-00772-8.CrossRef

Mayrhofer K, Niedersüß-Beke D. Best of ASCO 2021—bladder cancer. memo. 2021;14(4). https://doi.org/10.1007/s12254-021-00765-7.CrossRef

Weiss L. ASCO 2021—an update on metastastic colorectal cancer. memo. 2021;14(4). https://doi.org/10.1007/s12254-021-00763-9.CrossRef

Titel: Best of ASCO 2021
verfasst von: Univ.-Prof. Dr. Ewald Wöll
Publikationsdatum: 01.12.2021
Verlag: Springer Vienna
Schlagwort: ASCO 2021
Erschienen in: memo - Magazine of European Medical Oncology / Ausgabe 4/2021
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI: https://doi.org/10.1007/s12254-021-00768-4

Neuroendocrine neoplasms of the lung: a pathology update

Open Access
short review

The double-edged sword of immune checkpoint inhibition in advanced staged thymic epithelial tumours

comment

Pancytopenia—a diagnostic challenge?

short review

Detection of acquired resistance mutation ALK G1202R after treatment with alectinib and response of lorlatinib

case report

Best of ASCO 2021—bladder cancer

ASCO 2021
short review

ASCO 2021—an update on metastastic colorectal cancer

Open Access
ASCO 2021
short review

Springer Medizin Österreich

Best of ASCO 2021

Excerpt

Weitere Artikel der Ausgabe 4/2021

Neuroendocrine neoplasms of the lung: a pathology update

The double-edged sword of immune checkpoint inhibition in advanced staged thymic epithelial tumours

Pancytopenia—a diagnostic challenge?

Detection of acquired resistance mutation ALK G1202R after treatment with alectinib and response of lorlatinib

Best of ASCO 2021—bladder cancer

ASCO 2021—an update on metastastic colorectal cancer

Springer Medizin Österreich

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Neuroendocrine neoplasms of the lung: a pathology update

The double-edged sword of immune checkpoint inhibition in advanced staged thymic epithelial tumours

Pancytopenia—a diagnostic challenge?

Detection of acquired resistance mutation ALK G1202R after treatment with alectinib and response of lorlatinib

Best of ASCO 2021—bladder cancer

ASCO 2021—an update on metastastic colorectal cancer